Tosoh Acquires US Venture for Continuous Biopharma Production
Tosoh Corp. (TYO:4042) has acquired Semba Biosciences, Inc., a U.S.-based chromatography equipment company. The Japanese firm aims through this deal…… Please subscribe to read the full story.
Interview: Asahi Kasei Senior Executive Officer Hideyuki Yamagishi Discusses Strategy for Specialty Solutions
Asahi Kasei Corp.’s (TYO:3407) Specialty Solutions strategic business unit (SBU) oversees operations for the likes of LiB separators and semiconductor…… Please subscribe to read the full story.
Tokyo Tech Devises a New Generation of BPA for Use in Chemical Surgery
Progress continues to be made in the realm of chemical surgery. Also known as base editing, this relatively new technique…… Please subscribe to read the full story.
Interview: Sumitomo Chemical President Keiichi Iwata Talks Industry Trends, Business Strategy
Sumitomo Chemical Co. Ltd. (TYO:4005) is facing a range of new opportunities and considerations as it heads into 2022. The…… Please subscribe to read the full story.
Chiyoda Readies to Develop Catalysts in Aim of Making Fuel Ammonia a Practical Reality
Chiyoda Corp. (TYO:6366) is making ground in its efforts to get fuel ammonia implemented in society. The company was recently…… Please subscribe to read the full story.
Column: China’s “Dual Carbon” Target Creates Waves in Chemical Sector
Faced with the 14th Five-Year Plan that the Chinese government has laid out for 2021–2025, key provincial authorities in the…… Please subscribe to read the full story.
Turmoil in Ukraine Hits European Chemicals Market; Asia Stands to Follow
Russia’s invasion of Ukraine has been going on for close to three weeks now, and the effects of this are…… Please subscribe to read the full story.
Sumitomo Chemical Tackles Carbon Footprint – Part 1: Leading the Charge to Standardize Industry Rules
Sumitomo Chemical Co. Ltd. (TYO:4005) has started sharing free-of-charge a tool it has developed for calculating the carbon footprint of…… Please subscribe to read the full story.
Kaneka Looks to Boost Health Care Business Sales to 300B Yen With New Medical Products
Kaneka Corp. (TYO:4118) plans to bring a raft of new products to market via its medical business, which deals with…… Please subscribe to read the full story.
Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
Asahi Kasei Medical Co. Ltd. recently announced that it will acquire California-based Bionova Scientific LLC, a CDMO for biopharmaceuticals. The…… Please subscribe to read the full story.
